| Followers | 10 |
| Posts | 1467 |
| Boards Moderated | 0 |
| Alias Born | 07/16/2006 |
Monday, October 06, 2014 5:32:34 PM
Warning Label: This only applies if you’re admitted to the hospital. The facts and figures may not be totally accurate, or completely false. Do your own due diligence! NNVC could be dangerous to your life. Having been tried on ~6,000 animals and shown to have no toxicity, and having incredible efficacy in animal trials (1,000 times more effective than Tamiflu, an FDA approved drug) the FDA might require NNVC to attach a warning label to the vials of the cides.
You may not get well by using this product! Your body has a better than 50% chance of preventing your death without taking the nanocide. You’re in this hospital because your body alone is not defeating this disease. The great care you are receiving from your doctors and nurses may not prevent the disease from killing you. If you body cannot diagnose and manufacture sufficient antibodies to overcome the virus fast enough you may die or have permeate damage to one or more organs. Even if you take this product you may still die. If you do die may we suggest that you allow your body to be donated and used to determine if the virus killed you or was it a result of NNVC’s product. To date no toxicity has been found in any of the lab tests, but we are still checking. NNVC claims the cide is agnostic to your system (this means the cide does not interact with any of the cells in your body, it simply floats around looking for virus organisms to join with. After they join the virus is disassembled and cannot do any more damage to your body. Both the disassembled virus and Nanoviruscide are then eliminated naturally. It will circulate in your blood stream until it is naturally eliminated by your kidneys, around 28 days post infusion. If you still among the living you may be asked to return to the doctor’s office and allow some additional testing. These tests may help future persons who become infected by the virus.
You may not get well by using this product! Your body has a better than 50% chance of preventing your death without taking the nanocide. You’re in this hospital because your body alone is not defeating this disease. The great care you are receiving from your doctors and nurses may not prevent the disease from killing you. If you body cannot diagnose and manufacture sufficient antibodies to overcome the virus fast enough you may die or have permeate damage to one or more organs. Even if you take this product you may still die. If you do die may we suggest that you allow your body to be donated and used to determine if the virus killed you or was it a result of NNVC’s product. To date no toxicity has been found in any of the lab tests, but we are still checking. NNVC claims the cide is agnostic to your system (this means the cide does not interact with any of the cells in your body, it simply floats around looking for virus organisms to join with. After they join the virus is disassembled and cannot do any more damage to your body. Both the disassembled virus and Nanoviruscide are then eliminated naturally. It will circulate in your blood stream until it is naturally eliminated by your kidneys, around 28 days post infusion. If you still among the living you may be asked to return to the doctor’s office and allow some additional testing. These tests may help future persons who become infected by the virus.
Recent NNVC News
- Deadly Measles Cases Accentuate the Need for a Treatment - NV-387 is Here to Help Patients and Control Spread, Says NanoViricides • ACCESS Newswire • 04/21/2026 12:30:00 PM
- Measles Rare Pediatric Disease Drug Designation Application Filed for NV-387, PRV Provides for Strong Business Case, Says NanoViricides • ACCESS Newswire • 04/07/2026 12:30:00 PM
- Phase II Clinical Trial of Monkeypox Treatment by NV-387 to Commence Soon, Announces NanoViricides • ACCESS Newswire • 04/01/2026 12:30:00 PM
- NanoViricides Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete • ACCESS Newswire • 03/11/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:30:47 PM
- MPox Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides • ACCESS Newswire • 02/12/2026 01:30:00 PM
- Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides • ACCESS Newswire • 02/10/2026 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/30/2025 09:30:18 PM
- Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 12/16/2025 09:30:05 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/15/2025 09:26:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/26/2025 09:30:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:32:10 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/12/2025 07:54:28 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/12/2025 04:29:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/01/2025 09:07:54 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/29/2025 08:33:17 PM
